Viral factors may affect the association between IFNL3 genotype and hepatic steatosis. Limitations of our study include retrospective nature of the study and small sample size. Furthermore, HCV genotype and ethnicity could affect the results. Recently, HCV treatment by IFN-free DAA regimen has been shown to affect host lipid metabolism, suggesting the role of HCV replication and/or core protein on lipid homeostasis